Psychotropic prescribing in catalonia: Results from an epidemiological study

Family Practice

Volumn 29, Issue 2, 2012, Pages 154-162

  Rubio valera, Maria ^a,b   Fernández, Ana ^a,b   Luciano, Juan V ^a,b   Hughes, Carmel M ^c   Pinto meza, Alejandra ^a,b   Moreno küstner, Berta ^b,d,e   Palao, Diego J ^f   Haro, Josep Maria ^a,g   Serrano blanco, Antoni ^a,b  

^a PARC SANITARI SANT JOAN DE DÉU   (Spain)

^b Institut Universitari d'Investigació en Ciències de la Salut IUNICS   (Spain)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d Hospital University Carlos Haya de Málaga   (Spain)

^e UNIVERSITY OF MÁLAGA   (Spain)

^f UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^g CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

Author keywords

Drug prescriptions; Mental disorders; Pharmacoepidemiology; Primary health care; Psychotropic drugs

Indexed keywords

ANXIOLYTIC AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADULT; AGE; AGED; ARTICLE; CONSULTATION; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EDUCATIONAL STATUS; ELECTRONIC MEDICAL RECORD; FEMALE; GENDER; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MENTAL DISEASE; PRESCRIPTION; PSYCHOLOGICAL WELL BEING; SELF CONCEPT; SOCIAL STATUS; SPAIN;

EID: 84859230855     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmr078     Document Type: Article

References (40)

1. van Rijswijk E, Borghuis M, van de LE, Zitman F, van Weel C. Treatment of mental health problems in general practice: a survey of psychotropics prescribed and other treatments provided. Int J Clin Pharmacol Ther 2007; 45: 23-9.
2. Fernandez A, Haro JM, Codony M et al. Treatment adequacy of anxiety and depressive disorders: primary versus specialised care in Spain. J Affect Disord 2006; 96: 9-20.
3. Ohayon MM, Lader MH. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom. J Clin Psychiatry 2002; 63: 817-25.
4. Ohayon MM, Caulet M, Priest RG, Guilleminault C. Psychotropic medication consumption patterns in the UK general population. J Clin Epidemiol 1998; 51: 273-83.
5. Mari JJ, Almeida-Filho N, Coutinho E et al. The epidemiology of psychotropic use in the city of Sao Paulo. Psychol Med 1993; 23: 467-74.
6. Mateo Fernández R, Rupérez Cordero O, Hernando Blázquez MA, Delgado Nicolá s MA, Sanchez González R. The consumption of psychoactive drugs in primary care. Aten Primaria 1997; 19: 47-50.
7. Bushnell J, McLeod D, Dowell A et al. The treatment of common mental health problems in general practice. Fam Pract 2006; 23: 53-9.
8. Linden M, Lecrubier Y, Bellantuono C et al. The prescribing of psychotropic drugs by primary care physicians: an international collaborative study. J Clin Psychopharmacol 1999; 19: 132-40.
9. Joukamaa M, Sohlman B, Lehtinen V. The prescription of psychotropic drugs in primary health care. Acta Psychiatr Scand 1995; 92: 359-64.
10. Prueksaritanond S, Tubtimtes S, Pumkompol T, Sukying C. Psychotropic drug prescribing in the family medicine out-patient clinic, Ramathibodi Hospital. J Med Assoc Thai 2009; 92: 266-72.
11. Secades Villa R, Rodríguez García E, Valderrey Barbero J et al. Use of psychoactive drugs in patients attending GPs' surgeries in the Principality of Asturias (Spain). Psicothema 2003; 15: 650-5.
12. Weisberg RB, Dyck I, Culpepper L, Keller MB. Psychiatric treatment in primary care patients with anxiety disorders: a comparison of care received from primary care providers and psychiatrists. Am J Psychiatry 2007; 164: 276-82.
13. Kisely S, Linden M, Bellantuono C, Simon G, Jones J. Why are patients prescribed psychotropic drugs by general practitioners? Results of an international study. Psychol Med 2000; 30: 1217-25.
14. Hickie IB, Davenport TA, Naismith SL et al. Treatment of common mental disorders in Australian general practice. Med J Aust 2001; 175 (suppl): S25-30.
15. Walters P, Ashworth M, Tylee A. Ethnic density, physical illness, social deprivation and antidepressant prescribing in primary care: ecological study. Br J Psychiatry 2008; 193: 235-9, doi:10.1192/bjp.bp.107.038299.
16. Morrison J, Anderson MJ, Sutton M et al. Factors influencing variation in prescribing of antidepressants by general practices in Scotland. Br J Gen Pract 2009; 59: e25-31.
17. Hull SA, Cornwell J, Harvey C, Eldridge S, Bare PO. Prescribing rates for psychotropic medication amongst east London general practices: low rates where Asian populations are greatest. Fam Pract 2001; 18: 167-73.
18. Søndergaard J, Vach K, Kragstrup J, Andersen M. Impact of pharmaceutical representative visits on GPs' drug preferences. Fam Pract 2009; 26: 204-9.
19. Caudill TS, Johnson MS, Rich EC, McKinney WP. Physicians, pharmaceutical sales representatives, and the cost of prescribing. Arch Fam Med 1996; 5: 201-6.
20. Serrano-Blanco A, Palao DJ, Luciano JV et al. Prevalence of mental disorders in primary care: results from the diagnosis and treatment of mental disorders in primary care study (DASMAP). Soc Psychiatry Psychiatr Epidemiol 2010; 45: 201-10.
21. FirstMB, Spitzer RL, GibbonM, WilliamJB. Structured Clinical InterviewAxis IDSM-IVDisorders, Research Version (SCID-RV). Washington, DC: American Psychiatric Press, 1996.
22. First MB, Spitzer RL, Gibbon M, William JB. Entrevista Clínica Estructurada Para Los Trastornos Del Eje I Del DSM-IV. Barcelona, Spain: Masson ed, 1999.
23. Sheehan DV, Lecrubier Y, Sheehan KH et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSMIV and ICD-10. J Clin Psychiatry 1998; 59 (suppl 20): 22-33.
24. Ferrando L, Franco AL, Soto M et al. MINI International Neuropsychiatric Interview. Spanish Version 5.0.0. DSM-IV. Madrid, Spain: Instituto IAP, 1998.
25. Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol 1996; 11 (suppl 3): 89-95.
26. Bobes J, Badía X, Luque A et al. Validation of the Spanish version of the Liebowitz social anxiety scale, social anxiety and distress scale and Sheehan disability inventory for the evaluation of social phobia. Med Clin (Barc) 1999; 112: 530-8.
27. Luciano JV, Bertsch J, Salvador-Carulla L et al. Factor structure internal consistency and construct validity of the Sheehan Disability Scale in a Spanish primary care sample. J Eval Clin Pract 2010; 16: 895-901, doi:10.1111/j.1365-2753.2009.01211.x.
28. Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989; 129: 125-37.
29. StataCorp. Stata Statistical Software: Release 11. College Station, TX: StataCorp LP, 2009.
30. Demyttenaere K, Bruffaerts R, Posada-Villa J et al. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA 2004; 291: 2581-90.
31. García-Armesto S, Abadía-Taira MB, Durán A, Hernández-Quevedo C, Bernal-Delgado E. Spain: health system review. Health Syst Transit 2010; 12: 1-295.
32. Fernández A, Pinto-Meza A, Bellón JA et al. Is major depression adequately diagnosed and treated by general practitioners? Results from an epidemiological study. Gen Hosp Psychiatry 2010; 32: 201-9, doi:10.1016/j.genhosppsych.2009.11.015.
33. Olfson M, Broadhead WE, Weissman MM et al. Subthreshold psychiatric symptoms in a primary care group practice. Arch Gen Psychiatry 1996; 53: 880-6.
34. Kendrick T, Dowrick C, McBride A et al. Management of depression in UK general practice in relation to scores on depression severity questionnaires: analysis of medical record data. BMJ 2009; 338: b750, doi:10.1136/bmj.b750.
35. Kessler D, Lloyd K, Lewis G, Gray DP. Cross sectional study of symptom attribution and recognition of depression and anxiety in primary care. BMJ 1999; 318: 436-9.
36. Vedsted P, Sørensen HT, Mortensen JT. Drug prescription for adult frequent attenders in Danish general practice: a population-based study. Pharmacoepidemiol Drug Saf 2004; 13: 717-24.
37. McIntosh A, Cohen A, Turnbull N et al. Clinical Guidelines and Evidence Review for Panic Disorder and Generalised Anxiety Disorder. Sheffield, UK: University of Sheffield, London, National Collaborating Centre for Primary Care, 2004, http://guidance.nice.org.uk/CG22 (accessed on 19 December 2010).
38. National Institute for Health and Clinical Excellence (NHS). Depression: The Treatment and Management of Depression in Adults (updated edition). National Clinical Practice Guideline 90. Leicester, UK: The British Psychological Society, 2010. http://guidance.nice.org.uk/CG90 (accessed on 19 December 2010).
39. Bull SA, Hu XH, Hunkeler EM et al. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA 2002; 288: 1403-9.
40. WHOInternationalWorkingGroup forDrug StatisticsMethodology, WHO Collaborating Centre for Drug Statistics Methodology, WHO Collaborating Centre For Drug Utilization Research and Clinical Pharmacological Services. Introduction to Drug Utilization Research. Geneva, Switzerland: World Health Organization, 2003. http://www.whocc.no/use_of_atc_ddd/(accessed on 1 July 2011).